|
Apabetalone and Potential COVID-19 Effectiveness
|
12
|
Resverlogix Corp.
|
Oct 26, 2020 09:01AM
|
|
24.6M USD Financing
|
2
|
Zenith Epigenetics
|
May 16, 2016 07:03PM
|
|
A bit dated but still relevant article
|
6
|
Zenith Epigenetics
|
Jun 15, 2018 07:19PM
|
|
Active Sites for Phase 3 Trial
|
6
|
Resverlogix Corp.
|
Feb 18, 2016 07:15PM
|
|
Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 02:00PM
|
|
AGM - High Level Summary
|
7
|
Zenith Epigenetics
|
Jan 07, 2016 03:54PM
|
|
AGM - Jan 7, 2016 - Details
|
10
|
Zenith Epigenetics
|
Jan 08, 2016 10:43AM
|
|
AGM 2018 - Masila Notes
|
17
|
Resverlogix Corp.
|
Sep 12, 2018 08:01PM
|
|
AGM 2018 - Masila Notes
|
8
|
Zenith Epigenetics
|
Sep 13, 2018 09:46AM
|
|
AGM in Oct
|
2
|
Resverlogix Corp.
|
Sep 23, 2019 10:52AM
|
|
Analyst Rating Change Notice
|
3
|
Resverlogix Corp.
|
Jan 09, 2017 08:45AM
|
|
Anne McCaffrey passing
|
17
|
Resverlogix Corp.
|
Jun 04, 2021 11:51AM
|
|
Another reason for Zenith to get busy with a Nasdaq listing
|
4
|
Zenith Epigenetics
|
Oct 03, 2016 12:47PM
|
|
Article in National Post Feb 11
|
11
|
Resverlogix Corp.
|
Feb 12, 2022 09:38AM
|
|
Awaken Dormant DNA, Epigenetically - Article in GEN
|
6
|
Zenith Epigenetics
|
Jan 12, 2018 06:03PM
|
|
Beacon reiterates assessment
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 07:38PM
|
|
Beacon report spreading
|
7
|
Resverlogix Corp.
|
Dec 07, 2017 08:06PM
|
|
BET Inhibitors may help Overcome a Newly Recognized Form of Resistance to Prostate Cancer Drugs
|
5
|
Zenith Epigenetics
|
Jun 22, 2021 09:34AM
|
|
Clovis' Rubracra
|
6
|
Zenith Epigenetics
|
Oct 03, 2018 01:02PM
|
|
Coincidence
|
10
|
Resverlogix Corp.
|
Nov 11, 2015 12:04PM
|
